ASX - By Stock
|
MYX |
Re:
Ann: 2024 Half Year Investor Presentation
|
|
CarlesPuyol
|
140 |
49K |
11 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
140
|
49K
|
11
|
|
ASX - By Stock
|
MYX |
Re:
fair price $13.0
|
|
CarlesPuyol
|
24 |
13K |
6 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
24
|
13K
|
6
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Appendix 4E and Statutory Accounts
|
|
CarlesPuyol
|
8 |
3.0K |
0 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
8
|
3.0K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: 2022 Full Year Media Release
|
|
CarlesPuyol
|
17 |
8.3K |
0 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
17
|
8.3K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma CEO announces plan to retire
|
|
CarlesPuyol
|
88 |
38K |
13 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
88
|
38K
|
13
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma announces sale of Metrics Contract Services
|
|
CarlesPuyol
|
183 |
84K |
9 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
183
|
84K
|
9
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma announces sale of Metrics Contract Services
|
|
CarlesPuyol
|
183 |
84K |
3 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
183
|
84K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: FDA approval of HALOETTE, a generic version of NUVARING
|
|
CarlesPuyol
|
26 |
10K |
1 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
26
|
10K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma appoints new CFO
|
|
CarlesPuyol
|
18 |
9.2K |
9 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
18
|
9.2K
|
9
|
|
ASX - By Stock
|
MYX |
Re:
MYX CHART
|
|
CarlesPuyol
|
537 |
240K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
537
|
240K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
MYX CHART
|
|
CarlesPuyol
|
537 |
240K |
11 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
537
|
240K
|
11
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma expands US dermatology portfolio
|
|
CarlesPuyol
|
53 |
20K |
3 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
53
|
20K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Results of Meeting
|
|
CarlesPuyol
|
11 |
6.1K |
1 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
11
|
6.1K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
MYX CHART
|
|
CarlesPuyol
|
537 |
240K |
3 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
537
|
240K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: 2021 AGM Notice of Meeting and Shareholder Pack
|
|
CarlesPuyol
|
19 |
11K |
4 |
24/10/21 |
24/10/21 |
ASX - By Stock
|
19
|
11K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
Ann: 2021 AGM Notice of Meeting and Shareholder Pack
|
|
CarlesPuyol
|
19 |
11K |
4 |
22/10/21 |
22/10/21 |
ASX - By Stock
|
19
|
11K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
MYX CHART
|
|
CarlesPuyol
|
537 |
240K |
6 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
537
|
240K
|
6
|
|
ASX - By Stock
|
MYX |
Re:
MYX CHART
|
|
CarlesPuyol
|
537 |
240K |
5 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
537
|
240K
|
5
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MAYNE PHARMA provides FDA update on generic NUVARING
|
|
CarlesPuyol
|
62 |
30K |
8 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
62
|
30K
|
8
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MAYNE PHARMA provides FDA update on generic NUVARING
|
|
CarlesPuyol
|
62 |
30K |
2 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
62
|
30K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MAYNE PHARMA provides FDA update on generic NUVARING
|
|
CarlesPuyol
|
62 |
30K |
1 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
62
|
30K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
MYX CHART
|
|
CarlesPuyol
|
537 |
240K |
8 |
20/09/21 |
20/09/21 |
ASX - By Stock
|
537
|
240K
|
8
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Change of Director's Interest Notice
|
|
CarlesPuyol
|
22 |
8.3K |
2 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
22
|
8.3K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
MYX CHART
|
|
CarlesPuyol
|
537 |
240K |
1 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
537
|
240K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: FDA approval of novel oral contraceptive NEXTSTELLIS
|
|
CarlesPuyol
|
85 |
38K |
0 |
04/09/21 |
04/09/21 |
ASX - By Stock
|
85
|
38K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
MYX CHART
|
|
CarlesPuyol
|
537 |
240K |
2 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
537
|
240K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Time to get in the game
|
|
CarlesPuyol
|
5 |
2.6K |
2 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
5
|
2.6K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
MYX CHART
|
|
CarlesPuyol
|
537 |
240K |
3 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
537
|
240K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
Z1P potential Take over by Ebay or Amazon
|
|
CarlesPuyol
|
13 |
5.0K |
1 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
13
|
5.0K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
News: MYX Mayne Pharma Group Posts FY Loss From Ordinary Activities After Income Tax Attributable...
|
|
CarlesPuyol
|
5 |
2.5K |
2 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
5
|
2.5K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma board renewal and new Chairman
|
|
CarlesPuyol
|
20 |
9.2K |
3 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
20
|
9.2K
|
3
|
|
ASX - By Stock
|
LNK |
Re:
Ann: Notification of buy-back - LNK
|
|
CarlesPuyol
|
2 |
833 |
2 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
2
|
833
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma board renewal and new Chairman
|
|
CarlesPuyol
|
20 |
9.2K |
8 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
20
|
9.2K
|
8
|
|
ASX - By Stock
|
MYX |
Re:
General Discussion Topics
|
|
CarlesPuyol
|
336 |
130K |
1 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
336
|
130K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
General Discussion Topics
|
|
CarlesPuyol
|
336 |
130K |
1 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
336
|
130K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Proposed issue of securities - Z1P
|
|
CarlesPuyol
|
10 |
3.7K |
2 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
10
|
3.7K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Share holder registry
|
|
CarlesPuyol
|
19 |
6.8K |
2 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
19
|
6.8K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Share holder registry
|
|
CarlesPuyol
|
19 |
6.8K |
5 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
19
|
6.8K
|
5
|
|
ASX - By Stock
|
MYX |
Re:
General Discussion Topics
|
|
CarlesPuyol
|
336 |
130K |
2 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
336
|
130K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
General Discussion Topics
|
|
CarlesPuyol
|
336 |
130K |
1 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
336
|
130K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Class action proceeding
|
|
CarlesPuyol
|
60 |
22K |
1 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
60
|
22K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Class action proceeding
|
|
CarlesPuyol
|
60 |
22K |
3 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
60
|
22K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Class action proceeding
|
|
CarlesPuyol
|
60 |
22K |
8 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
60
|
22K
|
8
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Class action proceeding
|
|
CarlesPuyol
|
60 |
22K |
0 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
60
|
22K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Lapse of performance rights
|
|
CarlesPuyol
|
3 |
1.4K |
9 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
3
|
1.4K
|
9
|
|
ASX - By Stock
|
MYX |
Re:
Changing of the the Guard - why is it not happening?
|
|
CarlesPuyol
|
4 |
1.6K |
1 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
4
|
1.6K
|
1
|
|
ASX - By Stock
|
MYX |
Changing of the the Guard - why is it not happening?
|
|
CarlesPuyol
|
4 |
1.6K |
2 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
4
|
1.6K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Q4 FY21 - Record Results Building on Global Momentum
|
|
CarlesPuyol
|
690 |
217K |
3 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
690
|
217K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Q4 FY21 - Record Results Building on Global Momentum
|
|
CarlesPuyol
|
690 |
217K |
5 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
690
|
217K
|
5
|
|
ASX - By Stock
|
ZIP Technology |
Re:
Breaking news and Zip to the moon
|
|
CarlesPuyol
|
104 |
41K |
3 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
104
|
41K
|
3
|
|